Viewing Study NCT06363994


Ignite Creation Date: 2025-12-25 @ 1:47 AM
Ignite Modification Date: 2025-12-26 @ 12:05 AM
Study NCT ID: NCT06363994
Status: RECRUITING
Last Update Posted: 2024-12-27
First Post: 2024-04-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL
Sponsor: InnoCare Pharma Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module